Last reviewed · How we verify

NCT07390994: PIX-PHENO

The PICCOLETO IX PHENO Study

Not yet recruiting Last updated 5 February 2026
What this trial tests

trial in Coronary Artery Disease in 600 participants. Not yet recruiting.

Timeline
9 January 2026
Primary endpoint
10 March 2027
20 April 2027

Quick facts

Lead sponsorFondazione Ricerca e Innovazione Cardiovascolare ETS
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment600
Start date9 January 2026
Primary completion10 March 2027
Estimated completion20 April 2027

Conditions studied

Sponsor

Fondazione Ricerca e Innovazione Cardiovascolare ETS — full company profile →

Who can join

18 and older, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate whether pre-procedural OCT-derived de novo coronary lesion phenotype (lipid-rich, fibrotic, calcific; and ACS mechanisms such as plaque rupture/erosion/calcified nodule) is associated with clinical outcomes after DCB angioplasty.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

Other Fondazione Ricerca e Innovazione Cardiovascolare ETS trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07390994.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing